Published in J Clin Microbiol on February 01, 1985
Pathophysiology of Campylobacter enteritis. Microbiol Rev (1986) 4.94
Human campylobacteriosis in developing countries. Emerg Infect Dis (2002) 3.14
Mutation in the peb1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice. Infect Immun (1998) 2.14
Host-pathogen interactions in Campylobacter infections: the host perspective. Clin Microbiol Rev (2008) 1.76
Pathogenic properties of Campylobacter jejuni: assay and correlation with clinical manifestations. Infect Immun (1985) 1.63
Experimental Campylobacter jejuni infection in Macaca nemestrina. Infect Immun (1989) 1.56
Influence of strain characteristics and immunity on the epidemiology of Campylobacter infections in Thailand. J Clin Microbiol (1988) 1.27
A Campylobacter jejuni homolog of the LcrD/FlbF family of proteins is necessary for flagellar biogenesis. Infect Immun (1993) 1.26
Immunogenicity and protective efficacy of a prototype Campylobacter killed whole-cell vaccine in mice. Infect Immun (1995) 1.24
Mucosal and systemic immunity to Campylobacter jejuni in rabbits after gastric inoculation. Infect Immun (1988) 1.24
Immune response to Campylobacter jejuni and Campylobacter coli in a cohort of children from birth to 2 years of age. Infect Immun (1989) 1.20
Distribution and serotypes of Campylobacter jejuni and Campylobacter coli in enteric Campylobacter strains isolated from children in the Central African Republic. J Clin Microbiol (1986) 1.16
Modulation of mucosal immunity against Campylobacter jejuni by orally administered cytokines. Antimicrob Agents Chemother (1993) 1.10
Evidence of reinfection with multiple strains of Campylobacter jejuni and Campylobacter coli in Macaca nemestrina housed under hyperendemic conditions. Infect Immun (1990) 1.06
Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans. Infect Immun (2010) 1.05
Human immune response to Campylobacter jejuni proteins expressed in vivo. Infect Immun (1992) 1.03
Long-term antibody responses following human infection with Campylobacter jejuni. Clin Exp Immunol (2002) 0.97
Recrudescent Campylobacter jejuni infection in an immunocompetent adult following experimental infection with a well-characterized organism. Clin Vaccine Immunol (2009) 0.94
Cholesterol depletion reduces entry of Campylobacter jejuni cytolethal distending toxin and attenuates intoxication of host cells. Infect Immun (2011) 0.91
Immune response of athymic and euthymic germfree mice to Campylobacter spp. Infect Immun (1986) 0.90
Prospective study of Campylobacter jejuni infection in Chilean infants evaluated by culture and serology. J Clin Microbiol (1989) 0.85
Incidence of Campylobacter infection in infants in western Algeria and the possible protective role of breast feeding. Epidemiol Infect (1990) 0.84
Local immune responses to the Campylobacter flagellin in acute Campylobacter gastrointestinal infection. J Clin Microbiol (1992) 0.82
Prevalence and determinants of Campylobacter infection among under five children with acute watery diarrhea in Mwanza, North Tanzania. Arch Public Health (2014) 0.81
Immunoglobulin KM genes in Guillain-Barré syndrome. Neurogenetics (2003) 0.81
Immunoglobulin A antibodies directed against Campylobacter jejuni flagellin present in breast-milk. Epidemiol Infect (1994) 0.76
Bactericidal properties of Campylobacter jejuni-specific immunoglobulin M antibodies in commercial immunoglobulin preparations. Antimicrob Agents Chemother (1995) 0.76
Serologic host response to Helicobacter pylori and Campylobacter jejuni in socially housed Rhesus macaques (Macaca mulatta). Gut Pathog (2012) 0.75
Selective primary health care: an interim strategy for disease control in developing countries. N Engl J Med (1979) 10.02
Campylobacter enteritis. N Engl J Med (1981) 7.98
Epidemiology of Campylobacter jejuni infections. Epidemiol Rev (1983) 7.06
Campylobacter enteritis in the United States. A multicenter study. Ann Intern Med (1983) 4.60
Detection of enteric campylobacteriosis in children. J Clin Microbiol (1979) 4.57
Plasma immunoglobulin concentrations in a West African (Gambian) community and in a group of healthy British adults. Clin Exp Immunol (1968) 3.53
Campylobacter enteritis - the first five years. J Hyg (Lond) (1982) 3.25
Isolation of Campylobacter fetus subsp. jejuni from Bangladeshi children. J Clin Microbiol (1980) 2.92
A proposed mechanism for natural immunity to enterobacterial pathogens. J Immunol (1968) 2.66
Incidence and severity of rotavirus and Escherichia coli diarrhoea in rural Bangladesh. Implications for vaccine development. Lancet (1981) 2.65
Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infect Immun (1984) 2.41
Serum immunoglobulin levels in healthy children and adults. Clin Exp Immunol (1969) 2.15
Epidemiologic and clinical features of endemic Campylobacter jejuni infection in Bangladesh. J Infect Dis (1983) 1.84
Antibodies to heat-labile Escherichia coli enterotoxin in Apaches in Whiteriver, Arizona. Infect Immun (1975) 1.75
Persistent Campylobacter jejuni infection in an immunocompromised patient. Ann Intern Med (1984) 1.62
Prevalence of Campylobacter fetus subsp. jejuni in healthy populations in southern India. J Clin Microbiol (1982) 1.57
Enterotoxigenic Escherichia coli diarrhoea: acquired immunity and transmission in an endemic area. Bull World Health Organ (1981) 1.54
Acquisition of serum antibody to Norwalk Virus and rotavirus and relation to diarrhea in a longitudinal study of young children in rural Bangladesh. J Infect Dis (1982) 1.46
COPROANTIBODY AND SERUM ANTIBODY IN CHOLERA PATIENTS. J Infect Dis (1965) 1.26
Campylobacter enteritis in Denver. West J Med (1982) 1.23
Campylobacter enteritis in immune-deficient patients. Ann Intern Med (1982) 1.11
Immunoglobulin concentrations in sera of normal children: quantitation against an international reference preparation. Clin Chem (1974) 1.05
Age-specific prevalence of antibody to rotavirus, Escherichia coli heat-labile enterotoxin, Norwalk virus, and hepatitis A virus in a rural community in Thailand. J Clin Microbiol (1983) 1.02
Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med (1979) 12.90
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem (1995) 12.61
Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med (1991) 11.98
Helicobacter pylori. Clin Microbiol Rev (1997) 9.22
The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor. J Infect Dis (1985) 9.18
Campylobacter enteritis. N Engl J Med (1981) 7.98
Detection of an adherence factor of enteropathogenic Escherichia coli with a DNA probe. J Infect Dis (1985) 7.78
Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun (1993) 7.75
Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology (1987) 7.27
New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol Rev (1983) 7.16
Epidemiology of Campylobacter jejuni infections. Epidemiol Rev (1983) 7.06
Experimental Campylobacter jejuni infection in humans. J Infect Dis (1988) 7.05
Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem (1992) 6.54
Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem (1994) 6.09
Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst (1995) 6.07
Survival of Campylobacter fetus subsp. jejuni in biological milieus. J Clin Microbiol (1980) 6.04
Campylobacter pylori antibodies in humans. Ann Intern Med (1988) 6.02
Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest (1995) 6.02
Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun (1990) 5.85
Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med (1989) 5.78
Epidemic Yersinia enterocolitica infection due to contaminated chocolate milk. N Engl J Med (1978) 5.39
Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology (1997) 5.24
30 years of campylobacters: biochemical characteristics and a biotyping proposal for Campylobacter jejuni. J Clin Microbiol (1982) 5.19
Cholera and other vibrioses in the United States. N Engl J Med (1985) 5.17
Intrafamilial clustering of Helicobacter pylori infection. N Engl J Med (1990) 5.09
Endemic cholera in rural Bangladesh, 1966-1980. Am J Epidemiol (1982) 4.93
Ethics and international research. BMJ (1997) 4.70
Campylobacter enteritis in the United States. A multicenter study. Ann Intern Med (1983) 4.60
Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group. J Pediatr (1999) 4.57
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44
Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology (1995) 4.42
The epidemiology of Helicobacter pylori infection. Epidemiol Rev (1991) 4.40
A review of human salmonellosis: III. Magnitude of Salmonella infection in the United States. Rev Infect Dis (1988) 4.28
Purification and characterization of urease from Helicobacter pylori. J Biol Chem (1990) 4.22
Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun (1995) 4.19
Exclusive breastfeeding reduces acute respiratory infection and diarrhea deaths among infants in Dhaka slums. Pediatrics (2001) 4.05
Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol (1995) 3.97
A two-year study of bacterial, viral, and parasitic agents associated with diarrhea in rural Bangladesh. J Infect Dis (1980) 3.96
Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials. Am J Clin Nutr (2000) 3.77
Handwashing to prevent diarrhea in day-care centers. Am J Epidemiol (1981) 3.75
Duration of infection-derived immunity to cholera. J Infect Dis (1981) 3.60
Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect Immun (1991) 3.57
Validation of postmortem interviews to ascertain selected causes of death in children. Int J Epidemiol (1990) 3.42
Meta-analysis of intervention trials on case-management of pneumonia in community settings. Lancet (1992) 3.38
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Growth, survival, and resistance of the Legionnaires' disease bacterium. Ann Intern Med (1979) 3.36
Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae. J Infect Dis (1982) 3.28
Identification and characterization of Campylobacter jejuni outer membrane proteins. Infect Immun (1983) 3.24
Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol (1995) 3.23
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med (1994) 3.19
Effect of El Niño and ambient temperature on hospital admissions for diarrhoeal diseases in Peruvian children. Lancet (2000) 3.11
Isolation of Campylobacter fetus subsp. jejuni from migratory waterfowl. J Clin Microbiol (1980) 3.11
Giardiasis in day-care centers: evidence of person-to-person transmission. Pediatrics (1977) 3.06
Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med (1992) 3.03
Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest (1991) 3.00
Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology (1996) 2.96
Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci U S A (1998) 2.96
Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst (1997) 2.95
Isolation of Campylobacter fetus subsp. jejuni from Bangladeshi children. J Clin Microbiol (1980) 2.92
A review of human salmonellosis: I. Infective dose. Rev Infect Dis (1983) 2.91
Rates, timing and causes of neonatal deaths in rural India: implications for neonatal health programmes. Bull World Health Organ (2006) 2.90
Zinc supplementation in young children with acute diarrhea in India. N Engl J Med (1995) 2.89
Reservoirs for human campylobacteriosis. J Infect Dis (1980) 2.87
Detection of Listeria monocytogenes by using the polymerase chain reaction. Appl Environ Microbiol (1990) 2.84
Conservation and diversity of Campylobacter pyloridis major antigens. Infect Immun (1987) 2.82
Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am Physicians (1999) 2.77
Helicobacter pylori and gastroduodenal disease. Annu Rev Med (1992) 2.75
Malnutrition as an underlying cause of childhood deaths associated with infectious diseases in developing countries. Bull World Health Organ (2000) 2.74
Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol (1998) 2.73
Infant antibiotic exposures and early-life body mass. Int J Obes (Lond) (2012) 2.72
Susceptibility of Campylobacter isolates to the bactericidal activity of human serum. J Infect Dis (1985) 2.71
Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis (1990) 2.71
Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest (2001) 2.70
Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology. J Clin Microbiol (1985) 2.66
Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol (1998) 2.65
Longitudinal studies of infectious diseases and physical growth of children in rural Bangladesh. II. Incidence of diarrhea and association with known pathogens. Am J Epidemiol (1982) 2.65
Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology (1992) 2.65
Incidence and severity of rotavirus and Escherichia coli diarrhoea in rural Bangladesh. Implications for vaccine development. Lancet (1981) 2.65
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61
Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology (1991) 2.57
Methodological issues in diarrhoeal diseases epidemiology: definition of diarrhoeal episodes. Int J Epidemiol (1991) 2.56
Causes of childhood deaths in Bangladesh: results of a nationwide verbal autopsy study. Bull World Health Organ (1998) 2.53
Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. Am J Epidemiol (1985) 2.49
Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine. Infect Immun (1984) 2.48
Quasispecies development of Helicobacter pylori observed in paired isolates obtained years apart from the same host. J Infect Dis (2000) 2.42
Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infect Immun (1984) 2.41
Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect Immun (1994) 2.37
Effects of diarrhea associated with specific enteropathogens on the growth of children in rural Bangladesh. Pediatrics (1984) 2.37
Zinc supplementation in infants born small for gestational age reduces mortality: a prospective, randomized, controlled trial. Pediatrics (2001) 2.36
Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35
Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst (2001) 2.32
Epidemiology of common-source outbreaks of shigellosis in the United States, 1961-1975. Am J Epidemiol (1978) 2.30
Infant-feeding practices and their relationship with diarrheal and other diseases in Huascar (Lima), Peru. Pediatrics (1989) 2.28
Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J Infect Dis (1996) 2.24
Lipopolysaccharide characteristics of pathogenic campylobacters. Infect Immun (1985) 2.23
Campylobacter enteritis associated with unpasteurized milk. Am J Med (1979) 2.19
Effects of Cryptosporidium parvum infection in Peruvian children: growth faltering and subsequent catch-up growth. Am J Epidemiol (1998) 2.17
Campylobacter enteritis from untreated water in the Rocky Mountains. Ann Intern Med (1983) 2.17